Drugs Made In America Acquisition Corp. Ordinary Shares
DMAANASDAQFinancial ServicesShell Companies
Latest quote
$10.74
+$0.025 · +0.23%
DMAA company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
48
Fair Value
Momentum
40
Weakening
Sentiment
56
Mixed
Risk resilience
92
Low Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteDrugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
- Industry
- Shell Companies
- Sector
- Financial Services
- Headquarters
- US
- CEO
- Roger Bendelac
- Listed since
- Jan 27, 2025
- Employees
- 2
Market position
- Volume
- 82.21K
- 2.25× average
- Average volume
- 36.51K
- Average daily volume
- Market cap
- 260.98M USD
- Beta
- 0
- Market reference 1
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 217.85M USD
- P/E (TTM)
- 54.76×
- P/B (TTM)
- 1.57×
- P/S (TTM)
- 0×
- EV / EBITDA
- -77.36×
- Earnings yield
- 2.73%
- Free cash flow yield
- -0.25%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 0.00%
- Operating margin
- 0.00%
- Net margin
- 0.00%
- Return on equity
- 2.55%
- Return on assets
- 2.48%
- Return on invested capital
- -1.18%
Financial health
- Debt / equity
- 0.01×
- Current ratio
- 0.03×
Financial statements
Income trends
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 |
|---|---|---|
| Selling, general, and administrative | 2.82M USD | 479.73 USD |
| Operating expenses | 2.82M USD | 479.73 USD |
| Interest income | 8.76M USD | — |
| Depreciation and amortization | — | 479.73 USD |
| Operating income | −2.82M USD | −479 USD |
| Net income | 5.94M USD | −479 USD |
Company facts updated Aug 24, 2026.
Earnings
- Latest fiscal-year EPS
- 0.19
- FY2025
- Latest fiscal-year revenue
- 0 USD
- FY2025
Annual EPS trend
Reported history and fiscal-year consensus
Annual revenue trend
Reported history and fiscal-year consensus
DMAA peers
Continue in GoAI
Research DMAAresearch.disclaimer